Long-Term Complete Remission with nab-Paclitaxel, Bevacizumab, and Gemcitabine Combination Therapy in a Patient with Triple-Negative Metastatic Breast Cancer

Publisher： Karger

E-ISSN： 1662-6575|5|3|687-692

ISSN： 1662-6575

Source： Case Reports in Oncology, Vol.5, Iss.3, 2012-12, pp. : 687-692

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Strong and Sustained Response to Treatment with Carboplatin plus Nab-Paclitaxel in a Patient with Metastatic, Triple-Negative, BRCA1-Positive Breast Cancer

By  

Case Reports in Oncology, Vol. 7, Iss. 1, 2014-04 ,pp. : 252-259

Karger

Access to resources Recommend Favorite

A Near-Complete Response to Treatment with Gemcitabine plus nab®-Paclitaxel in a Patient with Metastatic Pancreatic Cancer and Poor Performance Status: A Case Report

By  

Case Reports in Oncology, Vol. 7, Iss. 3, 2014-10 ,pp. : 711-717

Karger

Access to resources Recommend Favorite

A Combination of Targeted Therapy with Chemotherapy Backbone Induces Response in a Treatment-Resistant Triple-Negative MCL1-Amplified Metastatic Breast Cancer Patient

By  

Case Reports in Oncology, Vol. 9, Iss. 1, 2016-02 ,pp. : 112-118

Karger

Access to resources Recommend Favorite

A Retrospective Series of Long-Term Survivors of Metastatic Breast Cancer in Complete Remission

By  

Oncology, Vol. 68, Iss. 1, 2005-04 ,pp. : 48-51

Karger

Access to resources Recommend Favorite

Long-Lasting Control of Triple-Negative Metastatic Breast Cancer with the Novel Drug Combination Ixabepilone and Capecitabine – Case Report

By  

Oncology Research and Treatment, Vol. 33, Iss. 1-2, 2010-01 ,pp. : 53-56

Karger

Access to resources Recommend Favorite